首页> 外文期刊>Emerging Infectious Diseases >Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae , S?o Paulo, Brazil
【24h】

Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae , S?o Paulo, Brazil

机译:巴西圣保罗耐碳青霉烯的肺炎克雷伯氏菌对多粘菌素B的抗性

获取原文
获取外文期刊封面目录资料

摘要

To the Editor: Infections caused by carbapenem-resistant Enterobacteriaceae have been associated with higher death rates than infections caused by carbapenem-susceptible strains, and resistant infections are mostly treated with polymyxins (1). Several outbreaks caused by carbapenem- and polymyxin-resistant Klebsiella pneumoniae (CPRKp) have been reported, mainly from Europe, and represent an emerging threat.Carbapenem-resistant K. pneumoniae (CRKp) are endemic to Brazil, where polymyxin B (PMB) has been largely used against infections caused by these microorganisms. We evaluated PMB resistance rates and clonal diversity among CRKp isolates from patients in S?o Paulo, Brazil. The study was approved by the Research Review Board of Fleury Institute in S?o Paulo.
机译:致编者:耐碳青霉烯的肠杆菌科细菌引起的感染的死亡率要比对碳青霉烯易感菌株引起的感染的死亡率更高,而且耐药菌大多用多粘菌素治疗(1)。据报道,由耐碳青霉烯和多黏菌素的肺炎克雷伯菌引起的几起暴发主要来自欧洲,并构成了新出现的威胁。对碳青霉烯耐药的肺炎克雷伯菌(CRKp)是巴西特有的,多粘菌素B(PMB)在被广泛用于抵抗这些微生物引起的感染。我们评估了巴西圣保罗患者CRKp分离株的PMB耐药率和克隆多样性。该研究得到了圣保罗弗勒里研究所研究评论委员会的批准。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号